In this episode of Hart2Heart with Dr. Mike Hart, Dr. Hart does a solo on GLP-1 agonists, especially Ozempic, and how they impact weight loss by reducing appetite and slowing gastric emptying. Originally designed for diabetes management, these drugs also help in lowering blood sugar levels. While many people have had success with weight loss, the host also discusses the challenges, such as side effects (nausea, gastrointestinal issues) and the potential return of cravings after stopping the medication. Dr. Hart stresses the importance of gradual dosing and mindful eating to sustain weight loss. Dr. Hart also touches on other GLP-1 drugs like Wegovy and oral forms like Rybelsus, comparing their effectiveness and applications.
Show Notes:
(0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart
(0:15) Dr. Hart is covering GLP-1 agonists and Ozempic
(1:00) Understanding GLP-1 agonists
(3:00) Different forms and dosages
(10:00) Benefits and uses of GLP-1 agonists
(11:30) Benefits beyond weight loss - cardiovascular health and neuroprotection
(13:00) Common and serious side effects
(17:03) How to avoid losing muscle mass
(20:00) The deets on “Ozempic Face”
(21:00) Mental state and cravings on Ozempic
(22:00) Managing cravings after stopping Ozempic
(28:00) Cost considerations of GLP-1 agonists
(29:30) Intro to Tirzepatide or Mounjaro
(31:30) Mechanisms and benefits of Tirzepatide
(33:30) Clinical trials and side effects of Tirzepatide
(36:00) Final thoughts and recommendations
---
Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap that exists in the medical community.
Connect on social with Dr. Mike Hart:
Social Links:
Instagram: @drmikehart
Twitter: @drmikehart
Facebook: @drmikehart
